BridgeMD
New treatment option for Head and Neck Surgery
Official title Preoperative Maxillary Nerve Block and Remifentanil Use in Septorhinoplasty
ClinicalTrials.gov ID: NCT07233538
What this study is testing
- What it's testing
- Septorhinoplasty is generally a prolonged surgical procedure that frequently involves osteotomy, which may lead to increased intraoperative remifentanil requirements. Moreover, it is often associated with significant bleeding due to the dense capillary network of the nasal region, making the maintenance of low-to-normal blood pressure preferable during surgery.
- This is a blinded study.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Those with an ASA (American Society of Anesthesiologists) score of I-II
- Those with a body mass index (BMI) between 18 and 30
- Those scheduled for elective surgery
- Those who are fully cooperative Patients who meet the criteria for septorhinoplasty surgery
You likely can't join if
- Conditions that constitute a relative contraindication to regional anesthesia (e.g., coagulation disorders, thrombocytopenia, severe valvular heart...
- International Normalized Ratio (INR) \> 1.5
- Facial paralysis or a history of facial paralysis
- History of central nervous system vascular disease
- Presence of neuropathy
- History of surgery in the region where the block will be performed
See the full eligibility criteria
- Those with an ASA (American Society of Anesthesiologists) score of I-II
- Those with a body mass index (BMI) between 18 and 30
- Those scheduled for elective surgery
- Those who are fully cooperative Patients who meet the criteria for septorhinoplasty surgery
- Conditions that constitute a relative contraindication to regional anesthesia (e.g., coagulation disorders, thrombocytopenia, severe valvular heart disease, local infection at the injection site, allergy to local...
- International Normalized Ratio (INR) \> 1.5
- Facial paralysis or a history of facial paralysis
- History of central nervous system vascular disease
- Presence of neuropathy
- History of surgery in the region where the block will be performed
- American Society of Anesthesiologists (ASA) physical status classification of III or higher
- Patients who do not want to participate in the study
- Patients with chronic pain or chronic opioid use
- Patients with alcohol, substance or drug addiction
- Patients with limited cooperation such as dementia, psychiatric disorders
- Pregnant and breastfeeding patients will be excluded from the study.
- Patients who cannot communicate in their native language will be excluded from the study
The study team makes the final eligibility decision.
Where it's taking place
- Ankara, Yenimahalle, Turkey (Türkiye)
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ankara, Yenimahalle, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.